These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


123 related items for PubMed ID: 4097634

  • 21. The treatment of parkinsonism with levodopa.
    Sutcliffe RL.
    Gerontol Clin (Basel); 1974; 16(1):151-6. PubMed ID: 4855131
    [No Abstract] [Full Text] [Related]

  • 22. Failures of L-dopa.
    Paulson GW.
    Ohio State Med J; 1973 Dec; 69(12):896-8. PubMed ID: 4769406
    [No Abstract] [Full Text] [Related]

  • 23. L-dopa in idiopathic parkinsonism.
    Calne DB, Stern GM, Spiers AS, Laurence DR.
    Lancet; 1969 Nov 08; 2(7628):973-6. PubMed ID: 4186975
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Treatment of Parkinson's disease with amantadine and levodopa. A one-year study.
    Parkes JD, Baxter RC, Curzon G, Knill-Jones RP, Knott PJ, Marsden CD, Tattersall R, Vollum D.
    Lancet; 1971 May 29; 1(7709):1083-6. PubMed ID: 4102620
    [No Abstract] [Full Text] [Related]

  • 26. Deanol in the treatment of levodopa-induced dyskinesias.
    Miller E.
    Neurology; 1974 Feb 29; 24(2):116-9. PubMed ID: 4855678
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Sustained levodopa therapy in parkinsonism.
    Hunter KR, Shaw KM, Laurence DR, Stern GM.
    Lancet; 1973 Oct 27; 2(7835):929-31. PubMed ID: 4126558
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Levodopa and parkinsonism: clinical impressions.
    Yahr MD.
    Clin Pharmacol Ther; 1971 Oct 27; 12(2):332-4. PubMed ID: 5577481
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Parkinson's disease treated with L-dopa. Three-year follow-up report.
    Mones RJ.
    N Y State J Med; 1972 Nov 15; 72(22):2749-50. PubMed ID: 4510706
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. L-Dopa in the treatment of parkinsonism.
    Calne DB.
    Clin Pharmacol Ther; 1970 Nov 15; 11(6):789-801. PubMed ID: 4921292
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. L-dopa in senile dementia.
    Van Woert MH, Heninger G, Rathey U, Bowers MB.
    Lancet; 1970 Mar 14; 1(7646):573-4. PubMed ID: 4190401
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.